Cargando…
Living-Donor Liver Transplantation and Hepatitis C
Hepatitis-C-virus- (HCV-) related end-stage cirrhosis is the primary indication for liver transplantation in many countries. Unfortunately, however, HCV is not eliminated by transplantation and graft reinfection is universal, resulting in fibrosis, cirrhosis, and finally graft decompression. In area...
Autores principales: | Akamatsu, Nobuhisa, Sugawara, Yasuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564275/ https://www.ncbi.nlm.nih.gov/pubmed/23401640 http://dx.doi.org/10.1155/2013/985972 |
Ejemplares similares
-
Living Donor Liver Transplantation for Patients with Hepatocellular Carcinoma
por: Akamatsu, Nobuhisa, et al.
Publicado: (2014) -
Liver Transplantation and Hepatitis C
por: Akamatsu, Nobuhisa, et al.
Publicado: (2012) -
Impact of Early Reoperation following Living-Donor Liver Transplantation on Graft Survival
por: Kawaguchi, Yoshikuni, et al.
Publicado: (2014) -
Microvascular Hepatic Artery Anastomosis in Living Donor Liver Transplantation for Erythropoietic Protoporphyria
por: Yamashita, Shuji, et al.
Publicado: (2020) -
Impact of Donor and Recipient Single Nucleotide Polymorphisms of IL28B rs8099917 in Living Donor Liver Transplantation for Hepatitis C
por: Harada, Nobuhiro, et al.
Publicado: (2014)